why choose us

First received: January 31, 2023

Clinical Trial: A Study of ASP1002 in Adults for Treatment of Solid Tumors

Study Status: Completed

Recruit Status: RECRUITING

Condition: Advanced Solid Tumors

Study Type: INTERVENTIONAL


Official Title: A Phase 1 Study of ASP1002 in Participants With Metastatic or Locally Advanced Solid Tumors

Brief Summary: ASP1002 is a potential new treatment for people with certain solid tumors.Before ASP1002 is available as a treatment, the researchers need to understand how it is processed by and acts upon the body.This information will help find a suitable dose and check for potential medical problems from the treatment.People in this study will be adults with locally advanced or metastatic solid tumors with high levels of a protein called claudin 4. Metastatic means the cancer has spread to other parts of the body.They will…

Read more